vs
Side-by-side financial comparison of GE HealthCare (GEHC) and LEAR CORP (LEA). Click either name above to swap in a different company.
LEAR CORP is the larger business by last-quarter revenue ($6.0B vs $5.1B, roughly 1.2× GE HealthCare). GE HealthCare runs the higher net margin — 8.0% vs 1.4%, a 6.6% gap on every dollar of revenue. On growth, GE HealthCare posted the faster year-over-year revenue change (7.4% vs 4.8%). LEAR CORP produced more free cash flow last quarter ($281.1M vs $112.0M). Over the past eight quarters, GE HealthCare's revenue compounded faster (3.0% CAGR vs -0.1%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
Lear Corporation is an American company that manufactures automotive seating and electrical systems. In 2019, it ranked #147 and in 2018, it ranked #148 on the Fortune 500 list.
GEHC vs LEA — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.1B | $6.0B |
| Net Profit | $411.0M | $82.7M |
| Gross Margin | 38.5% | 5.7% |
| Operating Margin | 10.0% | 2.6% |
| Net Margin | 8.0% | 1.4% |
| Revenue YoY | 7.4% | 4.8% |
| Net Profit YoY | -30.1% | -6.1% |
| EPS (diluted) | $0.85 | $1.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $5.1B | — | ||
| Q4 25 | $5.7B | $6.0B | ||
| Q3 25 | $5.1B | $5.7B | ||
| Q2 25 | $5.0B | $6.0B | ||
| Q1 25 | $4.8B | $5.6B | ||
| Q4 24 | $5.3B | $5.7B | ||
| Q3 24 | $4.9B | $5.6B | ||
| Q2 24 | $4.8B | $6.0B |
| Q1 26 | $411.0M | — | ||
| Q4 25 | $588.0M | $82.7M | ||
| Q3 25 | $446.0M | $108.2M | ||
| Q2 25 | $486.0M | $165.2M | ||
| Q1 25 | $564.0M | $80.7M | ||
| Q4 24 | $721.0M | $88.1M | ||
| Q3 24 | $470.0M | $135.8M | ||
| Q2 24 | $428.0M | $173.1M |
| Q1 26 | 38.5% | — | ||
| Q4 25 | 39.7% | 5.7% | ||
| Q3 25 | 38.7% | 6.4% | ||
| Q2 25 | 39.6% | 7.3% | ||
| Q1 25 | 42.1% | 6.5% | ||
| Q4 24 | 42.8% | 6.8% | ||
| Q3 24 | 41.7% | 7.3% | ||
| Q2 24 | 41.4% | 7.5% |
| Q1 26 | 10.0% | — | ||
| Q4 25 | 14.5% | 2.6% | ||
| Q3 25 | 12.7% | 3.4% | ||
| Q2 25 | 13.1% | 4.1% | ||
| Q1 25 | 13.2% | 3.3% | ||
| Q4 24 | 15.1% | 3.7% | ||
| Q3 24 | 13.9% | 3.9% | ||
| Q2 24 | 12.6% | 4.3% |
| Q1 26 | 8.0% | — | ||
| Q4 25 | 10.3% | 1.4% | ||
| Q3 25 | 8.7% | 1.9% | ||
| Q2 25 | 9.7% | 2.7% | ||
| Q1 25 | 11.8% | 1.5% | ||
| Q4 24 | 13.6% | 1.5% | ||
| Q3 24 | 9.7% | 2.4% | ||
| Q2 24 | 8.8% | 2.9% |
| Q1 26 | $0.85 | — | ||
| Q4 25 | $1.28 | $1.58 | ||
| Q3 25 | $0.98 | $2.02 | ||
| Q2 25 | $1.06 | $3.06 | ||
| Q1 25 | $1.23 | $1.49 | ||
| Q4 24 | $1.58 | $1.64 | ||
| Q3 24 | $1.02 | $2.41 | ||
| Q2 24 | $0.93 | $3.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.0B |
| Total DebtLower is stronger | $10.1B | $2.7B |
| Stockholders' EquityBook value | $10.7B | $5.0B |
| Total Assets | $37.1B | $14.8B |
| Debt / EquityLower = less leverage | 0.95× | 0.54× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.5B | $1.0B | ||
| Q3 25 | $4.0B | $1.0B | ||
| Q2 25 | $3.7B | $887.9M | ||
| Q1 25 | $2.5B | $779.9M | ||
| Q4 24 | $2.9B | $1.1B | ||
| Q3 24 | $3.5B | $763.9M | ||
| Q2 24 | $2.0B | $950.3M |
| Q1 26 | $10.1B | — | ||
| Q4 25 | $10.0B | $2.7B | ||
| Q3 25 | $10.3B | $2.8B | ||
| Q2 25 | $10.3B | $2.8B | ||
| Q1 25 | $8.8B | $2.7B | ||
| Q4 24 | $9.0B | $2.7B | ||
| Q3 24 | $10.3B | $2.8B | ||
| Q2 24 | $9.2B | $2.7B |
| Q1 26 | $10.7B | — | ||
| Q4 25 | $10.4B | $5.0B | ||
| Q3 25 | $10.0B | $5.1B | ||
| Q2 25 | $9.7B | $5.1B | ||
| Q1 25 | $9.2B | $4.7B | ||
| Q4 24 | $8.4B | $4.5B | ||
| Q3 24 | $8.3B | $4.8B | ||
| Q2 24 | $7.8B | $4.8B |
| Q1 26 | $37.1B | — | ||
| Q4 25 | $36.9B | $14.8B | ||
| Q3 25 | $36.1B | $15.2B | ||
| Q2 25 | $35.5B | $15.3B | ||
| Q1 25 | $33.6B | $14.6B | ||
| Q4 24 | $33.1B | $14.0B | ||
| Q3 24 | $33.9B | $14.8B | ||
| Q2 24 | $31.9B | $14.7B |
| Q1 26 | 0.95× | — | ||
| Q4 25 | 0.96× | 0.54× | ||
| Q3 25 | 1.03× | 0.54× | ||
| Q2 25 | 1.06× | 0.54× | ||
| Q1 25 | 0.95× | 0.59× | ||
| Q4 24 | 1.06× | 0.61× | ||
| Q3 24 | 1.24× | 0.58× | ||
| Q2 24 | 1.18× | 0.57× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $475.9M |
| Free Cash FlowOCF − Capex | $112.0M | $281.1M |
| FCF MarginFCF / Revenue | 2.2% | 4.7% |
| Capex IntensityCapex / Revenue | — | 3.3% |
| Cash ConversionOCF / Net Profit | — | 5.75× |
| TTM Free Cash FlowTrailing 4 quarters | — | $527.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $475.9M | ||
| Q3 25 | — | $444.4M | ||
| Q2 25 | $94.0M | $296.2M | ||
| Q1 25 | $250.0M | $-127.7M | ||
| Q4 24 | — | $680.8M | ||
| Q3 24 | — | $182.7M | ||
| Q2 24 | $-119.0M | $291.2M |
| Q1 26 | $112.0M | — | ||
| Q4 25 | — | $281.1M | ||
| Q3 25 | — | $307.0M | ||
| Q2 25 | $8.0M | $170.8M | ||
| Q1 25 | $98.0M | $-231.7M | ||
| Q4 24 | — | $488.7M | ||
| Q3 24 | — | $50.5M | ||
| Q2 24 | $-183.0M | $170.4M |
| Q1 26 | 2.2% | — | ||
| Q4 25 | — | 4.7% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | 0.2% | 2.8% | ||
| Q1 25 | 2.1% | -4.2% | ||
| Q4 24 | — | 8.6% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | -3.8% | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 3.3% | ||
| Q3 25 | 2.1% | 2.4% | ||
| Q2 25 | 1.7% | 2.1% | ||
| Q1 25 | 3.2% | 1.9% | ||
| Q4 24 | 1.9% | 3.4% | ||
| Q3 24 | 1.9% | 2.4% | ||
| Q2 24 | 1.3% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.75× | ||
| Q3 25 | — | 4.11× | ||
| Q2 25 | 0.19× | 1.79× | ||
| Q1 25 | 0.44× | -1.58× | ||
| Q4 24 | — | 7.73× | ||
| Q3 24 | — | 1.35× | ||
| Q2 24 | -0.28× | 1.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging revenues | $2.3B | 45% |
| AVS revenues | $1.3B | 26% |
| PDx revenues | $770.0M | 15% |
| PCS revenues | $704.0M | 14% |
| Other revenues | $18.0M | 0% |
LEA
| Other | $3.5B | 59% |
| Seating Segment | $1.9B | 32% |
| E Systems Segment | $520.6M | 9% |
